questionsmedicales.fr
Maladies du système immunitaire
Maladies auto-immunes
Maladies auto-immunes du système nerveux
Myasthénie
Myasthénie congénitale
Myasthénie congénitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Myasthénie congénitale : Questions médicales les plus fréquentes",
"headline": "Myasthénie congénitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Myasthénie congénitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Myasthénie congénitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Myasthénie",
"url": "https://questionsmedicales.fr/mesh/D009157",
"about": {
"@type": "MedicalCondition",
"name": "Myasthénie",
"code": {
"@type": "MedicalCode",
"code": "D009157",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Myasthénie congénitale",
"alternateName": "Myasthenia Gravis, Neonatal",
"code": {
"@type": "MedicalCode",
"code": "D020941",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nils Erik Gilhus",
"url": "https://questionsmedicales.fr/author/Nils%20Erik%20Gilhus",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Medicine, University of Bergen, Bergen, Norway. nils.gilhus@uib.no."
}
},
{
"@type": "Person",
"name": "Yuebing Li",
"url": "https://questionsmedicales.fr/author/Yuebing%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Henry J Kaminski",
"url": "https://questionsmedicales.fr/author/Henry%20J%20Kaminski",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology and Rehabilitation Medicine and."
}
},
{
"@type": "Person",
"name": "Gary Cutter",
"url": "https://questionsmedicales.fr/author/Gary%20Cutter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama."
}
},
{
"@type": "Person",
"name": "Akiyuki Uzawa",
"url": "https://questionsmedicales.fr/author/Akiyuki%20Uzawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Associations between prenatal exposure to phthalates and birth weight: A meta-analysis study.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37393820",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ecoenv.2023.115207"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Effectiveness of Psychological Interventions on the Impact of Trauma Exposure in Foster Care: A Meta-Analysis.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/38045839",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40653-023-00563-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37513846",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ph16070934"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between Lower Body Qualities and Change-of-Direction Performance: A Meta-Analysis.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37364608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2117-9490"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37380088",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amepre.2023.06.016"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Myasthénie",
"item": "https://questionsmedicales.fr/mesh/D009157"
},
{
"@type": "ListItem",
"position": 6,
"name": "Myasthénie congénitale",
"item": "https://questionsmedicales.fr/mesh/D020941"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Myasthénie congénitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Myasthénie congénitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Myasthénie congénitale",
"description": "Comment diagnostiquer la myasthénie congénitale ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier selon les patients ?\nQuel rôle joue l'historique familial dans le diagnostic ?\nPeut-on diagnostiquer la myasthénie congénitale à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Myasthénie congénitale",
"description": "Quels sont les symptômes principaux de la myasthénie congénitale ?\nLes symptômes peuvent-ils s'aggraver avec l'effort ?\nY a-t-il des symptômes oculaires associés ?\nLes symptômes apparaissent-ils à un âge spécifique ?\nLa myasthénie congénitale affecte-t-elle tous les muscles ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Myasthénie congénitale",
"description": "Peut-on prévenir la myasthénie congénitale ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes conseils génétiques sont-ils recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nY a-t-il des mesures préventives pour les nouveau-nés ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Myasthénie congénitale",
"description": "Quels traitements sont disponibles pour la myasthénie congénitale ?\nLes médicaments peuvent-ils améliorer les symptômes ?\nLa thérapie physique est-elle recommandée ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements sont-ils adaptés à tous les patients ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Myasthénie congénitale",
"description": "Quelles complications peuvent survenir avec la myasthénie congénitale ?\nLes crises myasthéniques sont-elles graves ?\nComment prévenir les complications respiratoires ?\nLes problèmes de déglutition sont-ils fréquents ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Myasthénie congénitale",
"description": "Quels sont les facteurs de risque de la myasthénie congénitale ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes mutations génétiques sont-elles un facteur déterminant ?\nLes anomalies congénitales sont-elles liées à la maladie ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D020941?mesh_terms=Network+Meta-Analysis&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la myasthénie congénitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, des tests électromyographiques et des analyses génétiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électromyographie, le test de stimulation répétée et des tests génétiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier selon les patients ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité et la nature des symptômes peuvent varier d'un patient à l'autre."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique familial dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique familial de myasthénie peut orienter le diagnostic vers une forme congénitale."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la myasthénie congénitale à la naissance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cas peuvent être diagnostiqués dès la naissance par des signes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la myasthénie congénitale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une faiblesse musculaire, des difficultés à bouger et une fatigue rapide."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec l'effort ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes tendent à s'aggraver avec l'effort et s'améliorent avec le repos."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes oculaires associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme le ptosis (chute de la paupière) et la diplopie (vision double) peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge spécifique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître dès la naissance ou se manifester plus tard dans l'enfance."
}
},
{
"@type": "Question",
"name": "La myasthénie congénitale affecte-t-elle tous les muscles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle affecte principalement les muscles volontaires, en particulier ceux des yeux et des membres."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la myasthénie congénitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Étant une maladie génétique, il n'existe pas de méthode de prévention connue."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les porteurs et informer les décisions reproductives."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conseils génétiques peuvent aider les familles à comprendre les risques de transmission."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance peut être nécessaire si des antécédents familiaux de myasthénie existent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les nouveau-nés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nouveau-nés à risque peuvent nécessiter une surveillance précoce pour détecter des symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la myasthénie congénitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils améliorer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les inhibiteurs de la cholinestérase peuvent améliorer la transmission neuromusculaire."
}
},
{
"@type": "Question",
"name": "La thérapie physique est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie physique peut aider à maintenir la force musculaire et la fonction."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la chirurgie pour retirer le thymus peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils adaptés à tous les patients ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements doivent être individualisés en fonction de la gravité et des symptômes du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la myasthénie congénitale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des crises myasthéniques, des infections respiratoires et des problèmes de déglutition."
}
},
{
"@type": "Question",
"name": "Les crises myasthéniques sont-elles graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent entraîner une faiblesse musculaire sévère et nécessiter une intervention médicale urgente."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications respiratoires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite et un traitement précoce des infections peuvent aider à prévenir ces complications."
}
},
{
"@type": "Question",
"name": "Les problèmes de déglutition sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les problèmes de déglutition peuvent survenir et nécessiter une évaluation par un spécialiste."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la myasthénie congénitale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des anomalies congénitales."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de myasthénie congénitale augmente le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les mutations génétiques sont-elles un facteur déterminant ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations dans des gènes spécifiques sont souvent responsables de la myasthénie congénitale."
}
},
{
"@type": "Question",
"name": "Les anomalies congénitales sont-elles liées à la maladie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies congénitales peuvent être associées à un risque accru de myasthénie congénitale."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, les facteurs environnementaux ne sont pas considérés comme des contributeurs significatifs."
}
}
]
}
]
}
Previous studies have suggested that phthalates are associated with birth weight. However, most phthalate metabolites have not been fully explored. Therefore, we conducted this meta-analysis to assess...
Due to prevalent exposure to trauma in the biological family, children in foster care often experience post-traumatic stress symptoms, difficulties in forming secure attachments with the caregivers, a...
The online version contains supplementary material available at 10.1007/s40653-023-00563-9....
Calcitonin gene-related peptide-targeted monoclonal antibodies (CGRP mAbs) are increasingly being used as preventive treatments for migraine. Their effectiveness and safety were established through nu...
The aim of the present study is to determine the associations between lower body muscle strength qualities and change of direction (CoD) performance. Three databases were used to perform a systematic ...
The hepatitis C virus (HCV) epidemic remains a public health problem worldwide. A systematic review and meta-analysis were conducted to provide evidence of outcomes attained across the HCV care cascad...
Studies from North America, Europe, and Australia (January 2014 through March 2021) reporting on HCV care cascade outcomes (screening to cure) were included. When calculating the proportions of indivi...
Sixty-five studies comprising 7,402,185 individuals were identified. Among individuals with positive HCV ribonucleic acid test results, 62% (95% CI=55%, 70%) attended their first care appointment, 41%...
Despite the availability of effective all-oral direct-acting antiviral therapies, persistent gaps remain across the HCV care cascade, especially among traditionally marginalized populations. Public he...
This study aimed to evaluate and compare the risk of dental caries in between human immunodeficiency virus (HIV)-infected and uninfected children and adolescents. An electronic search was performed on...
Liver transplantation has made significant progress in recent decades. Lung cancer is one of the most frequently occurring cancers after liver transplantation. However, the risk of lung cancer among l...
All eligible studies published in PubMed, Web of Science, and Embase from database inception to April 2022 were included. Standardized incidence ratio was used to describe the increased risk of lung c...
Our meta-analysis included 15 studies, which involved 76,897 liver transplantation patients. Studies included in this review showed significant heterogeneity (I...
Our meta-analysis suggests that liver transplant patients are twice as likely as the general population to develop lung cancer. Further research on risk factors for the development of lung cancer afte...
Hepcidin, the master iron regulatory hormone, has been shown to peak 3-6 h postexercise, and is likely a major contributor to the prevalence of iron deficiency in athletes. Although multiple studies h...
The aim of this individual participant data meta-analysis was to identify key factors influencing the hepcidin-exercise response....
Following a systematic review of the literature, a one-stage meta-analysis with mixed-effects linear regression, using a stepwise approach to select the best-fit model, was employed....
We show that exercise is associated with a 1.5-2.5-fold increase in hepcidin concentrations, with pre-exercise hepcidin concentration accounting for ~ 44% of the variance in 3 h postexercise hepcidin ...
Our analysis reveals the complex interplay of characteristics of both athlete and exercise session in the hepcidin response to exercise and highlights the need for further investigation into unaccount...
A wide range of psychological treatments have been found to reduce the symptoms of irritable bowel syndrome (IBS) but their relative effects are unclear. In this systematic review and meta-analysis, w...
Malignant spinal cord compression (MSCC) has been noted in 3-5% of children with primary tumours. MSCC can be associated with permanent neurological deficits and prompt treatment is necessary. Our aim...
A systematic review of the English language was undertaken using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Search criteria included 'MSCC in children,...
From a total of 17 articles identified, a final 7 were analysed (Level III/IV). Neuroblastoma constituted the most common cause for MSCC in children (62.7%) followed by sarcoma (14.2%). Soft tissue sa...
Neuroblastoma is the most common cause for MSCC in children (62.7%) followed by sarcoma (14.2%), whilst soft tissue sarcomas constituted the most frequent cause of MSCC in children > 5 years old. The ...